These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2188679)

  • 21. Immunology. Making class II presentable.
    Schmid SL; Jackson MR
    Nature; 1994 May; 369(6476):103-4. PubMed ID: 8177315
    [No Abstract]   [Full Text] [Related]  

  • 22. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules.
    Amigorena S; Bonnerot C
    Semin Immunol; 1999 Dec; 11(6):385-90. PubMed ID: 10625592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell-mediated association of peptide antigen and major histocompatibility complex protein detected by energy transfer in an evanescent wave-field.
    Watts TH; Gaub HE; McConnell HM
    Nature; 1986 Mar 13-19; 320(6058):179-81. PubMed ID: 2936964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of macrophage Ia and membrane IL 1 expression to antigen presentation.
    Kurt-Jones EA; Virgin HW; Unanue ER
    J Immunol; 1985 Dec; 135(6):3652-4. PubMed ID: 3934262
    [No Abstract]   [Full Text] [Related]  

  • 25. Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells.
    Kaiserlian D; Vidal K; Revillard JP
    Eur J Immunol; 1989 Aug; 19(8):1513-6. PubMed ID: 2570703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.
    Harding CV; Unanue ER
    Nature; 1990 Aug; 346(6284):574-6. PubMed ID: 2115981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
    Grant CF; Ali R; Povey S; Stockinger B
    Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-presenting cell-T cell interaction in the chicken is MHC class II antigen restricted.
    Vainio O; Veromaa T; Eerola E; Toivanen P; Ratcliffe MJ
    J Immunol; 1988 May; 140(9):2864-8. PubMed ID: 3258887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway.
    Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
    Cell Biol Int; 1994 May; 18(5):315-20. PubMed ID: 8049676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct and indirect recognition of pig class II antigens by human T cells.
    Yamada K; Sachs DH; DerSimonian H
    Transplant Proc; 1995 Feb; 27(1):258-9. PubMed ID: 7878993
    [No Abstract]   [Full Text] [Related]  

  • 31. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The recognition of MHC molecules by gamma delta T cells.
    Schild H; Chien YH
    Behring Inst Mitt; 1994 Jul; (94):113-23. PubMed ID: 7998905
    [No Abstract]   [Full Text] [Related]  

  • 33. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes.
    Stockinger B
    Eur J Immunol; 1992 May; 22(5):1271-8. PubMed ID: 1577067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen presentation in the rheumatoid joint.
    Geppert TD; Jasin HE
    J Rheumatol; 1991 Mar; 18(3):309-11. PubMed ID: 1713268
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigen-presenting cells for unprimed T cells.
    Sprent J; Schaefer M
    Immunol Today; 1989 Jan; 10(1):17-23. PubMed ID: 2526637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific B lymphocytes efficiently pick up, process and present antigen to T cells.
    Lanzavecchia A; Bove S
    Behring Inst Mitt; 1985 Aug; (77):82-7. PubMed ID: 3002320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC class II gene products specific autoreactive T cell clones provide inducer as well as amplifier function for B cell Ig production.
    Bensussan A; Milanese C; Meuer SC; Reinherz EL
    Behring Inst Mitt; 1985 Aug; (77):93-104. PubMed ID: 2417587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MHC class II restricted antigen presentation].
    Hirata S; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.